Most Recent
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
CBA has attacked two failed class actions' "misguided" appeal, arguing that requiring companies to disclose incomplete information to shareholders would distort the market.
The Full Court has heard that a judge's finding on materiality in two failed shareholder class actions against CBA could have “troubling” repercussions for insider trading cases and must be overturned.
A judge has called out the “combative correspondence” between solicitors at Corrs Chambers and another law firm in a construction defects suit.
Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
ASIC wants the Full Court to overturn a finding that Noumi waived privilege over a PwC report produced under a voluntary disclosure regime, arguing the regime benefits the public in making investigations more efficient.
A judge has overturned energy minister Chris Bowen's refusal to greenlight energy company Seadragon’s offshore wind farm project off the coast of Gippsland.
Former top silk Norman O'Bryan, who is facing criminal charges for his role in the notorious Banksia Securities class action, has secured a second adjournment of his case.
Australian Clinical Labs may seek to strike out part of the OAIC's case over a 2022 data breach, arguing it would unfairly allow the watchdog to allege both single and multiple contraventions of privacy law.
Crypto company Filecoin Foundation can't dodge a suit by a developer who says she was fired after complaining that a portion of her wages was paid in Filecoin tokens.